Different routes and formulations of melatonin in critically ill patients. A pharmacokinetic randomized study-Reference-Cited by-同舟云学术

Different routes and formulations of melatonin in critically ill patients. A pharmacokinetic randomized study

Published:2019-04-30 Issue: Volume: Page:
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Mistraletti Giovanni¹²^ORCID,Paroni Rita³,Umbrello Michele²,Moro Salihovic Bedrana¹,Coppola Silvia²,Froio Sara²,Finati Elena³,Gasco Paolo⁴,Savoca Adriana⁵,Manca Davide⁵,Chiumello Davide²³,Reiter Russel J.⁶,Iapichino Gaetano¹²

Affiliation:

1. Department of Pathophysiology and Transplantation Università degli Studi di Milano Milano Italy

2. S.C. Anesthesia and Intensive Care ASST Santi Paolo e Carlo, Ospedale San Paolo‐Polo Universitario Milano Italy

3. Department of Health Science Università degli Studi di Milano Milano Italy

4. Nanovector srl Torino Italy

5. Chemical Engineering Department Politecnico di Milano Milano Italy

6. Department of Cellular and Structural Biology University of Texas Health Science Centre San Antonio Texas

Funder

Regione Lombardia

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.13993

Reference35 articles.

1. Melatonin reduces the need for sedation in ICU patients: a randomized controlled trial;Mistraletti G;Minerva Anestesiol,2015

2. Melatonin pharmacological blood levels increase total antioxidant capacity in critically ill patients;Mistraletti G;Int J Mol Sci,2017

3. Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies;Wilhelmsen M;J Pineal Res,2011

4. Effects of melatonin treatment in septic newborns;Gitto E;Pediatr Res,2001

5. Potential use of melatonin in sleep and delirium in the critically ill;Bellapart J;Br J Anaesth,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in solid-lipid nanoparticle chemistry as drug delivery vehicles;International Journal of Polymeric Materials and Polymeric Biomaterials;2024-04-26

2. Melatonin as a therapeutic agent for alleviating endothelial dysfunction in cardiovascular diseases: Emphasis on oxidative stress;Biomedicine & Pharmacotherapy;2023-11

3. Solid Lipid Nanoparticles: Multitasking Nano-Carriers for Cancer Treatment;Pharmaceutics;2023-03-03

4. Melatonin: A Potential Candidate for the Treatment of Experimental and Clinical Perinatal Asphyxia;Molecules;2023-01-22

5. Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements;Nutrients;2022-09-22